ASX-listed Zelira Therapeutics has raised another US$3.25 million (A$4.89m) towards the cost of its US clinical […]
Category: Finance
Featuring updates on Australia’s ASX-listed cannabis and hemp companies including share price movements, ASX announcements, business and trading news.
